Allergan Inc., the Irvine-based maker of Botox, eye drugs and other products, won a round in court last week in a patent battle over its Latisse eyelash grower. A federal appeals court in Washington, ...

Botox generated $2.7B in global sales for 2024 Allergan Aesthetics scored a big legal patent infringement win tied to its blockbuster wrinkle-treatment Botox. A federal court in Delaware last month ...

A federal jury July 18 said Revance Therapeutics' skin medication infringed on patents for anti-wrinkle treatment Botox and owes AbbVie-owned Allergan $56 million. The lawsuit, filed by Ireland-based ...

Less than a week after Allergan and Duke University dropped their allegation that Novartis' Sandoz willfully infringed Duke’s patent for eyelash growth serum Latisse (bimatoprost), a federal jury in ...

Allergan Aesthetics launched its SkinMedica Even & Correct Collection Tuesday morning, featuring a suite of products targeting hyperpigmentation. The company noted that these SkinMedica offerings are ...

SAN FRANCISCO (CN) — A federal judge on Monday dismissed with prejudice a whistleblower lawsuit filed by a patent attorney against the drugmaker Allergan over two prescription drugs used to treat ...

U.S. District Judge Eli Richardson in Nashville, Tennessee, ruled, opens new tab that Allergan plausibly alleged that Revance had acquired and used some of its rival’s trade secrets amid a series of ...

An Illinois appellate court today affirmed a lower court's dismissal of a lawsuit involving the 2020 merger of North Chicago-based AbbVie and Irish drugmaker Allergan. Allergan shareholder Stephen ...

Skin-focused Sirona Biochem is liquidating its R&D subsidiary after a pair of financing deals and a licensing agreement with AbbVie’s Allergan Aesthetics fell apart. Sirona signed an agreement with ...